Brown Advisory
DNA icon

Brown Advisory’s Ginkgo Bioworks DNA Stock Holding History

Brown Advisory’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,191
Closed -$42.7K – 1273
2024
Q2 		$42.7K Sell
3,191
-2,731
-46% -$81.5K ﹤0.01% 1216
2024
Q1 		$275K Sell
5,922
-64
-1% -$3.31K ﹤0.01% 1091
2023
Q4 		$405K Buy
5,986
+880
+17% +$53.9K ﹤0.01% 981
2023
Q3 		$370K Sell
5,106
-1,008
-16% -$80.6K ﹤0.01% 976
2023
Q2 		$455K Buy
6,114
+1,982
+48% +$117K ﹤0.01% 932
2023
Q1 		$220K Buy
4,132
+18
+0.4% +$1.14K ﹤0.01% 1109
2022
Q4 		$278K Buy
4,114
+533
+15% +$49K ﹤0.01% 1043
2022
Q3 		$447K Buy
3,581
+248
+7% +$29.6K ﹤0.01% 885
2022
Q2 		$317K Buy
3,333
+2,208
+196% +$269K ﹤0.01% 945
2022
Q1 		$181K Buy
+1,125
New +$219K ﹤0.01% 1072

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return